Vascular endothelial growth factor (VEGF): Can we use it as prognostic factor in endometrial cancer?

Minerva Ginecologica

Volumn 58, Issue 5, 2006, Pages 411-415

  Balbi, G ^a   Monteverde, A ^a   Passaro, M ^a   Cassese, E ^a   Landino, I ^a   Visconti, S ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Endometrial neoplasms; Prognosis; Vascular endothelial growth factor

Indexed keywords

CISPLATIN; VASCULOTROPIN;

ABDOMINAL HYSTERECTOMY; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH VESSEL; PROGNOSIS; PROTEIN EXPRESSION; SALPINGOOOPHORECTOMY;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750911800     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statics. Cancer J Clin 1996;46:5-27.
2. Hoskins WJ, Perez CA, Young RC. Principles and Practice of Gynecologic Oncology. Philadelphia: Lippincott Williams and Wilkins; 2000.
3. Abulafia O, Triest WE, Sherer DM. Angiogenesis in malignancies of the female genital tract. Gynecol Oncol 1999;72:220-31.
4. Giatromanolaki A, Sivridis E, Brekken R, Thorp PE, Anastasiadis P, Gatter KC et al. The angiogenic "vascular endothelial growth factor/flk-1 (KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications. Cancer 2001;92:2569-77.
5. Fujisawa T, Watanabe J, Akaboshi M, Ohno E, Kuramoto H. Immunohistochemical study on VEGF expression in endometrial carcinoma - comparison with p53 expression, angiogenesis, and tumour histologic grade. J Cancer Res Clin Oncol 2001;127:668-74.
6. Fine BA, Valente PT, Feinstein GI, Dey T. EGF, flt-1, and KDR/FLK-1 as prognostic indicators in endometrial carcinoma. Gynecol Oncol 2000;76:33-9.
7. Yokoyama Y, Sato S, Futagami M, Fukushi Y, Sakamoto T, Umemoto M et al. Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma. Gynecol Oncol 2000;77:413-8.
8. Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF. Expression of vascular permeabilita factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer 1995;78:454-60.
9. Loverro G, Greco P, Vimercati A, Selvaggi L. Angiogenesis and endometrial carcinoma. Correlations with blood flow analysis by transvaginal color Doppler ultrasonography. Minerva Ginecol 1998;50: 83-7.
10. Lee CN, Cheng WF, Chen CA, Chu JS, Hsieh CY, Hsieh FJ. Angiogenesis of endometrial carcinomas assessed by measurement of intratumoral blood flow, microvessel density, and vascular endothelial growth factor levels. Obstet Gynecol 2000;96:615-21.
11. Hirai M, Nakagawara MD, Oosaki T, Hayashi Y, Hirono M, Yoshihara T. Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma. Gynecol Oncol 2001;80:181-8.
12. Abulafia O, Triest WE, Sherer DM, Hansen CC, Ghezzi F. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol 1995;86: 479-85.
13. Chen CA, Cheng WF, Lee CN, Wei LH, Chu JS, Hsiesh FG et al. Cytosol vascular endothelial growth factor in endometrial carcinoma. Correlation with disease-free survival. Gynecol Oncol 2001;80:207-12.
14. Obermair A, Wanner C, Bilgi S, Speicer P, Kaider A, Reinthaller A et al. Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am J Obstet Gynecol 1998;178:314-9.